Skip to main content
NCBI home page
Annals of Noninvasive Electrocardiology logoLink to Annals of Noninvasive Electrocardiology
. 2006 Oct 27;7(1):64–71. doi: 10.1111/j.1542-474X.2001.tb00141.x

Noninvasive Diagnosis of Cardiac Arrhythmias Using Adenosine Compounds

Bernard Belhassen 1,✉
PMCID: PMC7027643  PMID: 11844294

The content is available as a PDF (727.1 KB).

REFERENCES

  • 1. Drury A, Szent‐Gyorgyi A. The physiological activity of adenine compounds with special reference to their action upon mammalian heart. J Physiol (Lond) 1929;68:213–237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Belhassen B, Pelleg A. Electrophysiologic effects of adenosine triphosphate and adenosine on the mammalian heart: Clinical and experimental aspects. J Am Coll Cardiol 1984;4:414–424. [DOI] [PubMed] [Google Scholar]
  • 3. Pelleg A. Belardinelli L. Cardiac electrophysiology and pharmacology of adenosine: Basic and clinical aspects. Cardiovasc Res 1993;27:54–61. [DOI] [PubMed] [Google Scholar]
  • 4. Camm AJ, Garrat CJ. Adenosine and supraventricular tachycardia. N Engl J Med 1991;325:1621–1629. [DOI] [PubMed] [Google Scholar]
  • 5. Belhassen B, Pelleg A, Shoshani D, et al. Electrophysiologic effects of adenosine‐5′‐triphosphate on atrioventricular reentrant tachycardia. Circulation 1983;68:827–833. [DOI] [PubMed] [Google Scholar]
  • 6. DiMarco J, Sellers T, Berne R, et al. Adenosine: Electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation 1983;68: 1254–1263. [DOI] [PubMed] [Google Scholar]
  • 7. Belhassen B, Glick A, Laniado S. Comparative clinical and electrophysiologic effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia. Circulation 1988;77:795–805. [DOI] [PubMed] [Google Scholar]
  • 8. DiMarco JP, Miles W, Akhtar M, et al. Adenosine for par oxysmal supraventricular tachycardia: Dose ranging and comparison with verapamil. Assessment in placebo‐controlled, multicenter trials. The Adenosine for PSVT Study Group. Ann Intern Med 1990;113: 104–110. [DOI] [PubMed] [Google Scholar]
  • 9. Brignole M, Alboni P, Benditt D, et al. Guidelines on management (diagnosis and treatment) of syncope. Task Force on Syncope, European Society of Cardiology, Eur Heart J 2001;22: 1256–1306. [DOI] [PubMed] [Google Scholar]
  • 10. Motte G, Waynberger M, Lebars A, et al. L'adenosine triphosphorique dans les tachycardies paroxystiques. Interet diagnostique et therapeutique. Nouv Presse Med (Paris) 1972;1: 3057–3061. [PubMed] [Google Scholar]
  • 11. Sharma AD, Klein GJ, Yee R. Intravenous adenosine triphosphate during wide QRS tachycardia: Safety, therapeutic efficacy and diagnostic: utility. Am J Med 1990;88: 337–343. [DOI] [PubMed] [Google Scholar]
  • 12. Griffith MJ, Linker NJ, Ward DE, et al. Adenosine in the diagnosis of broad complex tachycardia. Lancet 1988;1:672–675. [DOI] [PubMed] [Google Scholar]
  • 13. Rankin AC, Oldroyd KG, Chong E, et al. Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias. Br Heart J 1989;62:195–203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Lerman BB, Belardinelli L, West A, et al. Adenosine‐senstive ventricular tachycardia: Evidence suggesting cyclic AMP‐mediated triggered activity. Circulation 1986;74:270–280. [DOI] [PubMed] [Google Scholar]
  • 15. Kobayashi Y, Kikushima S, Tanno K, et al. Sustained left ventricular tachycardia terminated by dipyridamole: Cyclic AMP‐mediated triggered activity. Circulation 1986;74: 270–280. [DOI] [PubMed] [Google Scholar]
  • 16. Kobayashi Y, Kikushima S, Tanno K, et al. Adenosine triphosphate sensitive ventricular tachycardia in man. PACE 1994;17:377–385. [DOI] [PubMed] [Google Scholar]
  • 17. Parham WA, Mehdirad AA, Biermann, et al. Adenosine‐induced ventricular fibrillation in a patient with stable ventricular tachycardia. J Interv Cardiac Electrophysiol 2001;5:71–74. [DOI] [PubMed] [Google Scholar]
  • 18. Garrat CJ, Griffith MJ, O'Nunain S, et al. Effects of intravenous adenosine on antegrade refractoriness of accessory atrioventricular connections. Circulation 1991;84: 1962–1968. [DOI] [PubMed] [Google Scholar]
  • 19. Rankin A, Rae A, Houston A. Acceleration of ventricular response to atrial flutter after intravenous adenosine. Br Heart J 1993;69:263–265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Grolleau R, Slama R. Les faisceaux de Kent inapparents. Chapter in: Le groupe de rythmologie de la societe francaise de cardiologie (ed): Les troubles du rythme cardiaque. Nanterre, editions Corbiere, 1978, pp. 187–197.
  • 21. Garrat C, Antoniou A, Griffith M, et al. Use of intravenous adenosine in sinus rhythm as a diagnostic test for latent preexcitation. Am J Cardiol 1990;65:868–873. [DOI] [PubMed] [Google Scholar]
  • 22. Belhassen B, Shoshani D, Laniado S. Unmasking of ventricular preexcitation by adenosine triphosphate: Its usefulness in the assessment of ajmaline test. Am Heart J 1989;118: 634–636. [DOI] [PubMed] [Google Scholar]
  • 23. Morgan‐Hughes N, Griffith M, McComb J. Intravenous adenosine can reveal accessory pathways not revealed by routine electrophysiologic testing. PACE 1993;16:2059–2063. [DOI] [PubMed] [Google Scholar]
  • 24. Alegret JM, Vinolas X, Palazon O, et al. Intermittent preexcitation after adenosine administration. Rev Esp Cardiol 2000;53:1132–1135. [PubMed] [Google Scholar]
  • 25. Belhassen B, Fish R, Glikson M, et al. Noninvasive diagnosis of dual AV node physiology in patients with AV nodal reentrant tachycardia by administration of adenosine‐5‐triphosphate during sinus rhythm. Circulation 1998;98:47–53. [DOI] [PubMed] [Google Scholar]
  • 26. Belhassen B, Fish R, Eldar M, et al. Simplified ATP test for noninvasive diagnosis of dual AV nodal physiology and assessment of results of slow pathway ablation in patients with AV nodal reentrant tachycardia. J Cardiovasc Electrophysiol 2000;11:255–261. [DOI] [PubMed] [Google Scholar]
  • 27. Tebbenjohanns J, Niehaus M, Korte T, et al. Noninvasive diagnosis in patients with undocumented tachycardias: Value of the adenosine test to predict AV nodal reentrant tachycardia. J Cardiovasc Electrophysiol 1999;10:916–923. [DOI] [PubMed] [Google Scholar]
  • 28. Sheahan RG, Klein GJ, Yee R, et al. Atrioventricular node reentry with “smooth” AV node function curves. A different arrhythmia substrate. Circulation 1996;93: 969–972. [DOI] [PubMed] [Google Scholar]
  • 29. Belhassen B, Fish R, Viskin S, et al. Adenosine ‐5′‐triphosphate test for the noninvasive diagnosis of concealed accessory pathway. J Am Coll Cardiol 2000;36:803–810. [DOI] [PubMed] [Google Scholar]
  • 30. Viskin S, Fish R, Glick A, et al. ATP test: A bedside diagnostic tool for identifying patients with palpitations who are likely to benefit from electrophysiologic evaluation. J Am Coll Cardiol 2001;38:173–177. [DOI] [PubMed] [Google Scholar]
  • 31. Tebbenjohanns J, Schumacher B Pfeiffer D, et al. Dose and rate‐dependent effects of adenosine on atrial action potential duration in humans. J Interv Card Electrophysiol 1997;1:39–40. [DOI] [PubMed] [Google Scholar]
  • 32. Strickberger SA, Man KC, Daoud EG, et al. Adenosineinduced atrial arrhythmias: A prospective analysis. Ann Intern Med 1997;96:1192–1200. [DOI] [PubMed] [Google Scholar]
  • 33. Wesley RC, Turnquest P. Torsades de pointes after intravenous adenosine in the presence of prolonged QT syndrome. Am Heart J 1992;123:794–796. [DOI] [PubMed] [Google Scholar]
  • 34. Celiker A, Tokel K, Cil E, et al. Adenosine induced torsades de pointes in a child with congenital long QT syndrome. PACE 1994;17:1814–1817. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Noninvasive Electrocardiology are provided here courtesy of International Society for Holter and Noninvasive Electrocardiology, Inc. and Wiley Periodicals, Inc.

RESOURCES